Latest Public Service Radio Minute
How Extreme Weather Changes Affect Mental HealthHow Extreme Weather Changes Affect Mental Health, MP3, 1.0MB
Listen to or download all our PSAsSupport Our Work
Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!
More InfoLatest News Around the Web
High School-Aged Teens Experiencing Depression Or Suicidal Ideation Appear To Have Increased Perceived Access To Firearms Compared With Their Peers, Research Suggests
Healio (5/26, Weldon) reported, “High school-aged teens experiencing depression or suicidal ideation have increased perceived access to firearms compared with their peers,” which “is especially concerning, the researchers said, because easy firearm access increases the risk for suicide, which is the second leading cause of death among adolescents.” After examining data “from a web survey of 1,914 parent-teen duos between June 24, 2020, and July 22, 2020, to generate a nationally representative sample of U.S. teens,” investigators found that “teens with depression or suicidality were 56% more likely…to believe they had easy and quick access to a firearm either on their property or off it.” The findings were published online May 22 in the journal Pediatrics.
Related Links:
— “Teens with depression, suicidality have increased perceived access to firearms “Rose Weldon, Healio, May 26, 2023
Evidence Growing Of Marijuana’s Association With Psychiatric Disorders
According to NBC News (5/26, Syal), “evidence is growing of marijuana’s association with psychiatric disorders such as depression, bipolar disorder and schizophrenia, especially in young men.” A studypublished online May 4 in the journal Psychological Medicine has found “evidence of an association between cannabis use disorder and schizophrenia,” a finding “most striking in young men ages 21-30, but was also seen in women of the same age.” The study examined “data from almost seven million men and women in Denmark over the course of a few decades to look for a link between schizophrenia and cannabis use disorder.”
Related Links:
— “Marijuana linked to mental health risks in young adults, growing evidence shows ” Akshay Syal, NBC News, May 26, 2023
Patients With Mental Health Disorders, Patients Taking Psychotropic Medications May Be At Increased Risk Of Sleep Disorders, Data Indicate
According to HCPlive (5/30, Walter), “patients with mental health disorders and patients who are taking psychotropic” medications “are at an increased risk of sleep disorders, including sleep apnea and insomnia,” researchers concluded in a study that “identified medical claim data from the Deseret Mutual Benefit Administrators…for mental disorders, psychotropic” medication “use, and demographic data for individuals aged 18-64 years between 2016-2020.” The findings were published online May 27 in the Annals of General Psychiatry.
Related Links:
— “Mental Disorders Associated With Sleep Apnea, Insomnia “Kenny Walter, HCPlive, May 30, 2023
Medicaid Coverage Tied To Increase In Telehealth Use, Healthcare Access, Study Suggests
mHealth Intelligence (5/25, Vaidya) reports, “Medicaid coverage of telehealth services between 2013 and 2019 was associated with significant increases in telehealth use and healthcare access, but private insurer coverage of telehealth during the same period was not similarly linked to increases in use and access, a recent study shows.” The findings were published online in Health Services Research.
Related Links:
— “Medicaid Coverage Linked to Rise in Telehealth Use, Healthcare Access “Anuja Vaidya, mHealth Intelligence, May 25, 2023
Withdrawing From Antidepressants Likely Not Tied To Efficacy Of Psilocybin In People With Treatment-Resistant Depression, Researchers Say
MedPage Today (5/25, Monaco) reports, “Withdrawing from antidepressants likely won’t affect how well psilocybin works for treatment-resistant depression, according to a phase IIb randomized controlled trial.” The findings of an “analysis of 233 participants treated with a single dose of the investigational psilocybin treatment COMP360” were presented at the American Psychiatric Association annual meeting.
Related Links:
— MedPage Today (requires login and subscription)
Foundation News
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.